Publication | Closed Access

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

Rheumatoid DisorderRheumatologyMedicineRheumatic DiseasesOptima TrialInflammatory Rheumatic DiseasePharmacotherapyMethotrexate AlonePsoriatic ArthritisRheumatoid Arthritis